drugset
drugset / Trial / NCT01601418

Effect of Single Doses of YF476 on Stomach Acidity

NCT01601418 ↗

Phase 1 Completed 12 enrolled Trio Medicines Ltd. James Black Foundation · collab
RandomizedCrossoverDouble-blindBasic science

Summary

The objective of the study was to assess the effect of a range of single oral doses of YF476 on pentagastrin-induced gastric acid output in healthy volunteers

Timeline

Start
2001-10
Primary completion
2002-01
Completion
2002-01

Drugs

EvaluationDrugModalityDoseRoute
Subject netazepide Protein / enzyme biologic 1 mg Oral
Subject netazepide Protein / enzyme biologic 5 mg Oral
Subject netazepide Protein / enzyme biologic 25 mg Oral
Subject netazepide Protein / enzyme biologic 100 mg Oral

Indications

gastrin secretion abnormality